Assessing the impact of heart failure specialist services on patient populations

<p>Abstract</p> <p>Background</p> <p>The assessment of the impact of healthcare interventions may help commissioners of healthcare services to make optimal decisions. This can be particularly the case if the impact assessment relates to specific patient populations and...

Full description

Bibliographic Details
Main Authors: Lyratzopoulos Georgios, Cook Gary A, McElduff Patrick, Havely Daniel, Edwards Richard, Heller Richard F
Format: Article
Language:English
Published: BMC 2004-05-01
Series:BMC Health Services Research
Online Access:http://www.biomedcentral.com/1472-6963/4/10
id doaj-4407e5d71361486686e9ca73a8839e82
record_format Article
spelling doaj-4407e5d71361486686e9ca73a8839e822020-11-25T00:26:35ZengBMCBMC Health Services Research1472-69632004-05-01411010.1186/1472-6963-4-10Assessing the impact of heart failure specialist services on patient populationsLyratzopoulos GeorgiosCook Gary AMcElduff PatrickHavely DanielEdwards RichardHeller Richard F<p>Abstract</p> <p>Background</p> <p>The assessment of the impact of healthcare interventions may help commissioners of healthcare services to make optimal decisions. This can be particularly the case if the impact assessment relates to specific patient populations and uses timely local data. We examined the potential impact on readmissions and mortality of specialist heart failure services capable of delivering treatments such as b-blockers and Nurse-Led Educational Intervention (N-LEI).</p> <p>Methods</p> <p>Statistical modelling of prevented or postponed events among previously hospitalised patients, using estimates of: treatment uptake and contraindications (based on local audit data); treatment effectiveness and intolerance (based on literature); and annual number of hospitalization per patient and annual risk of death (based on routine data).</p> <p>Results</p> <p>Optimal treatment uptake among eligible but untreated patients would over one year prevent or postpone 11% of all expected readmissions and 18% of all expected deaths for spironolactone, 13% of all expected readmisisons and 22% of all expected deaths for b-blockers (carvedilol) and 20% of all expected readmissions and an uncertain number of deaths for N-LEI. Optimal combined treatment uptake for all three interventions during one year among all eligible but untreated patients would prevent or postpone 37% of all expected readmissions and a minimum of 36% of all expected deaths.</p> <p>Conclusion</p> <p>In a population of previously hospitalised patients with low previous uptake of b-blockers and no uptake of N-LEI, optimal combined uptake of interventions through specialist heart failure services can potentially help prevent or postpone approximately four times as many readmissions and a minimum of twice as many deaths compared with simply optimising uptake of spironolactone (not necessarily requiring specialist services). Examination of the impact of different heart failure interventions can inform rational planning of relevant healthcare services.</p> http://www.biomedcentral.com/1472-6963/4/10
collection DOAJ
language English
format Article
sources DOAJ
author Lyratzopoulos Georgios
Cook Gary A
McElduff Patrick
Havely Daniel
Edwards Richard
Heller Richard F
spellingShingle Lyratzopoulos Georgios
Cook Gary A
McElduff Patrick
Havely Daniel
Edwards Richard
Heller Richard F
Assessing the impact of heart failure specialist services on patient populations
BMC Health Services Research
author_facet Lyratzopoulos Georgios
Cook Gary A
McElduff Patrick
Havely Daniel
Edwards Richard
Heller Richard F
author_sort Lyratzopoulos Georgios
title Assessing the impact of heart failure specialist services on patient populations
title_short Assessing the impact of heart failure specialist services on patient populations
title_full Assessing the impact of heart failure specialist services on patient populations
title_fullStr Assessing the impact of heart failure specialist services on patient populations
title_full_unstemmed Assessing the impact of heart failure specialist services on patient populations
title_sort assessing the impact of heart failure specialist services on patient populations
publisher BMC
series BMC Health Services Research
issn 1472-6963
publishDate 2004-05-01
description <p>Abstract</p> <p>Background</p> <p>The assessment of the impact of healthcare interventions may help commissioners of healthcare services to make optimal decisions. This can be particularly the case if the impact assessment relates to specific patient populations and uses timely local data. We examined the potential impact on readmissions and mortality of specialist heart failure services capable of delivering treatments such as b-blockers and Nurse-Led Educational Intervention (N-LEI).</p> <p>Methods</p> <p>Statistical modelling of prevented or postponed events among previously hospitalised patients, using estimates of: treatment uptake and contraindications (based on local audit data); treatment effectiveness and intolerance (based on literature); and annual number of hospitalization per patient and annual risk of death (based on routine data).</p> <p>Results</p> <p>Optimal treatment uptake among eligible but untreated patients would over one year prevent or postpone 11% of all expected readmissions and 18% of all expected deaths for spironolactone, 13% of all expected readmisisons and 22% of all expected deaths for b-blockers (carvedilol) and 20% of all expected readmissions and an uncertain number of deaths for N-LEI. Optimal combined treatment uptake for all three interventions during one year among all eligible but untreated patients would prevent or postpone 37% of all expected readmissions and a minimum of 36% of all expected deaths.</p> <p>Conclusion</p> <p>In a population of previously hospitalised patients with low previous uptake of b-blockers and no uptake of N-LEI, optimal combined uptake of interventions through specialist heart failure services can potentially help prevent or postpone approximately four times as many readmissions and a minimum of twice as many deaths compared with simply optimising uptake of spironolactone (not necessarily requiring specialist services). Examination of the impact of different heart failure interventions can inform rational planning of relevant healthcare services.</p>
url http://www.biomedcentral.com/1472-6963/4/10
work_keys_str_mv AT lyratzopoulosgeorgios assessingtheimpactofheartfailurespecialistservicesonpatientpopulations
AT cookgarya assessingtheimpactofheartfailurespecialistservicesonpatientpopulations
AT mcelduffpatrick assessingtheimpactofheartfailurespecialistservicesonpatientpopulations
AT havelydaniel assessingtheimpactofheartfailurespecialistservicesonpatientpopulations
AT edwardsrichard assessingtheimpactofheartfailurespecialistservicesonpatientpopulations
AT hellerrichardf assessingtheimpactofheartfailurespecialistservicesonpatientpopulations
_version_ 1725343921304764416